𝔖 Bobbio Scriptorium
✦   LIBER   ✦

E-cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion

✍ Scribed by M. Mareel; T. Boterberg; V. Noë; L. Van Hoorde; S. Vermeulen; E. Bruyneel; M. Bracke


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
120 KB
Volume
173
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Simultaneous loss of E-cadherin and cate
✍ de Leeuw, Wiljo J. F.; Berx, Geert; Vos, Carla B. J.; Peterse, Johannes L.; Van 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

## Loss of expression of the intercellular adhesion molecule E-cadherin frequently occurs in invasive lobular breast carcinomas as a result of mutational inactivation. Expression patterns of E-cadherin and the molecules comprising the cytoplasmic complex of adherens junctions, -, -and -catenin, we

Re-expression of E-cadherin, ?-catenin a
✍ Bukholm, I. K.; Nesland, J. M.; B�rresen-Dale, A.-L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Tumour cell invasion and metastasis are the processes which kill most cancer patients. Tumour cells with the greatest invasive and metastatic capacity may be those with the highest number of genetic aberrations. The present study has analysed the expression of several tumour-related proteins in both

An immunohistochemical examination of th
✍ Gonzalez, M. A.; Pinder, S. E.; Wencyk, P. M.; Bell, J. A.; Elston, C. W.; Nicho 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 2 views

This study examines the expression of the cell-cell adhesion molecules E-cadherin and its associated proteins, the catenins and the matrix-cell adhesion molecules 1-and 2-integrins, in primary invasive breast carcinoma. Expression was assessed immunohistochemically on frozen sections by semi-quantit

Relation between aberrant α-catenin expr
✍ Rainy Umbas; William B. Isaacs; Pierre Paul Bringuier; Yong Xue; Frans M.J. Debr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 151 KB 👁 1 views

It is now well documented that E-cadherin expression correlates inversely with tumor grade in various carcinomas including prostate cancer. We also demonstrated a statistically significant correlation between decreased E-cadherin expression and progression-free period in early stage patients treated